News CytoDyn Inc.

Equities

CYDY

US23283M1018

Market Closed - OTC Markets Other stock markets 03:59:38 2024-04-26 pm EDT			5-day change	1st Jan Change
0.143 ^USD	-2.05%		-7.74%	-26.67%

Apr. 15	CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	CI
Mar. 05	Transcript : CytoDyn Inc. - Special Call

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	Apr. 15	CI
Transcript : CytoDyn Inc. - Special Call	Mar. 05
CytoDyn Announces FDA Has Lifted Clinical Hold	Feb. 29	GL
CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma	Feb. 01	GL
CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma	Feb. 01	AQ
CytoDyn Inc. Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma	Feb. 01	CI
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO	Jan. 29	GL
Cytodyn Inc. Announces CFO Changes	Jan. 29	CI
CytoDyn Inc. Announces Appointment of Jacob Lalezari as CEO	Jan. 29	CI
Purcell & Lefkowitz LLP Announces Shareholder Investigation of CytoDyn Inc. (OTC: CYDY)	Jan. 18	PR
CytoDyn Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	Jan. 16	CI
CytoDyn Inc. announced a financing transaction	Dec. 28	CI
Transcript : CytoDyn Inc. - Special Call	Dec. 14
CytoDyn Announces Webcast to Provide Company Update	Dec. 07	GL
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO	Nov. 21	GL
CytoDyn Inc. Appoints Jacob Lalezari M.D. as Interim CEO	Nov. 21	CI
OPDP Comes Out Swinging With A Warning Letter On Unsubstantiated Efficacy	Nov. 08	AQ
November 2023 Letter to Shareholders	Nov. 03	GL
CytoDyn Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023	23-10-23	CI
CytoDyn Inc. Reports Earnings Results for the Full Year Ended May 31, 2023	23-09-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News CytoDyn Inc.

Equities

CYDY

US23283M1018

Summary

Filters